Alex Braun | Head-Investor Relations |
Dan O'Connell | Chief Executive Officer |
Eric Siemers | Chief Medical Officer |
Matt Zuga | Chief Financial Officer & Chief Business Officer |
Colin Bristow | UBS |
Paul Matteis | Stifel |
Tom Shrader | BTIG |
Pete Stavropoulos | Cantor Fitzgerald |
Charlie Yang | Bank of America |
Thank you for standing by, and welcome to the Acumen Pharmaceuticals Second Quarter 2023 Update Call. At this time, all participants are in a listen-only mode. There will be a brief overview followed by question-and-answer session. [Operator Instructions] Today's call is being recorded.
And I would now like to turn the call over to Alex Braun, Head of Investor Relations.